| Micalyn Kelley, APRN | |
|
109 Opp Ave, Andalusia, AL 36420-3812 | |
| (850) 444-4700 | |
| (850) 444-7497 |
| Full Name | Micalyn Kelley |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 3 Years |
| Location | 109 Opp Ave, Andalusia, Alabama |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1205588803 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363L00000X | Nurse Practitioner | 1-123835 (Alabama) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Andalusia Health | Andalusia, AL | Hospital |
| Mizell Memorial Hospital | Opp, AL | Hospital |
| Evergreen Medical Center | Evergreen, AL | Hospital |
| Baptist Hospital | Pensacola, FL | Hospital |
| Troy Regional Medical Center | Troy, AL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Pensacola Nephrology Pa | 7214832856 | 30 |
| Pensacola Nephrology Pa | 7214832856 | 30 |
News Archive
The use of statins and other lipid-lowering agents by older adults was not associated with a reduced risk of Alzheimer's disease or other types of dementia, according to a study in the July issue of Archives of Neurology.
For the third year in a row, the American Society of Clinical Oncology (ASCO) has included Erbitux® (cetuximab) research in its annual report, Clinical Cancer Advances, which features the most significant studies of 2010. The report cites as a notable advance this year the finding that BRAF mutation status is a prognostic, not predictive, marker for Erbitux efficacy in metastatic colorectal cancer (mCRC).
Egalet Corporation, a fully integrated specialty pharmaceutical company focused on developing, manufacturing and marketing innovative pain treatments, today announced the pricing of an underwritten public offering of 6,666,667 shares of its common stock at a public offering price of $11.25 per share.
Quitting alcohol may improve health-related quality of life for women, especially their mental well-being, according to a study from Hong Kong published in CMAJ.
› Verified 3 days ago
| Entity Name | Pensacola Nephrology Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1518969765 PECOS PAC ID: 7214832856 Enrollment ID: O20040429001260 |
News Archive
The use of statins and other lipid-lowering agents by older adults was not associated with a reduced risk of Alzheimer's disease or other types of dementia, according to a study in the July issue of Archives of Neurology.
For the third year in a row, the American Society of Clinical Oncology (ASCO) has included Erbitux® (cetuximab) research in its annual report, Clinical Cancer Advances, which features the most significant studies of 2010. The report cites as a notable advance this year the finding that BRAF mutation status is a prognostic, not predictive, marker for Erbitux efficacy in metastatic colorectal cancer (mCRC).
Egalet Corporation, a fully integrated specialty pharmaceutical company focused on developing, manufacturing and marketing innovative pain treatments, today announced the pricing of an underwritten public offering of 6,666,667 shares of its common stock at a public offering price of $11.25 per share.
Quitting alcohol may improve health-related quality of life for women, especially their mental well-being, according to a study from Hong Kong published in CMAJ.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Micalyn Kelley, APRN Po Box 11037, Pensacola, FL 32524-1037 Ph: (850) 444-4700 | Micalyn Kelley, APRN 109 Opp Ave, Andalusia, AL 36420-3812 Ph: (850) 444-4700 |
News Archive
The use of statins and other lipid-lowering agents by older adults was not associated with a reduced risk of Alzheimer's disease or other types of dementia, according to a study in the July issue of Archives of Neurology.
For the third year in a row, the American Society of Clinical Oncology (ASCO) has included Erbitux® (cetuximab) research in its annual report, Clinical Cancer Advances, which features the most significant studies of 2010. The report cites as a notable advance this year the finding that BRAF mutation status is a prognostic, not predictive, marker for Erbitux efficacy in metastatic colorectal cancer (mCRC).
Egalet Corporation, a fully integrated specialty pharmaceutical company focused on developing, manufacturing and marketing innovative pain treatments, today announced the pricing of an underwritten public offering of 6,666,667 shares of its common stock at a public offering price of $11.25 per share.
Quitting alcohol may improve health-related quality of life for women, especially their mental well-being, according to a study from Hong Kong published in CMAJ.
› Verified 3 days ago
Heide Sue Price, APRN Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 215 Medical Park Dr Ste 1, Andalusia, AL 36420 Phone: 334-222-4327 Fax: 334-222-4333 | |
Sarah Dowdy, Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 508 E Three Notch St Ste 100, Andalusia, AL 36420 Phone: 334-362-2015 | |
Mrs. Candace W Cassady, ARNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 104 Medical Park Dr., Andalusia, AL 36420 Phone: 334-222-2562 Fax: 334-222-2725 | |
Marc Chatman, CRNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 849 S Three Notch St, Andalusia, AL 36420 Phone: 334-222-8466 | |
Jacqueline Hope Veasey, Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 614 W Bypass, Andalusia, AL 36420 Phone: 334-222-0119 Fax: 334-427-9522 | |
Ricky L Lewis, CRNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 835 S Three Notch St, Andalusia, AL 36420 Phone: 334-222-8421 Fax: 334-222-1248 |